T3	Effect 0 31	Visceral herpesvirus infections
T5	Treatment 63 73	cytarabine
T4	Subject 35 52	leukemic patients
T8	Drug 63 74	cytarabine.
T9	Treat-Disorder 35 43	leukemic
T6	Adverse_event 32 34	in
E1	Adverse_event:T6